Table 1 |
||||
|
Antitumor activity of TW-37 in WSU-DLCL2 bearing SCID mice. |
||||
|
Agent* |
No. of Animals |
T/C (%) |
T-C (days) |
Log10 Kill (Gross) |
|
|
||||
|
Control |
5 |
0.0 |
0 22 |
0.0 |
|
TW-37 |
5 |
28 |
10 |
1.5 |
|
|
||||
|
*TW-37 was given at its MTD; 40 mg/kg × 3 days, via tail vein. |
||||
|
Al-Katib et al. Journal of Hematology & Oncology 2009 2:8 doi:10.1186/1756-8722-2-8 |
||||
